7,702 Shares in Trupanion, Inc. (NASDAQ:TRUP) Acquired by Fox Run Management L.L.C.

Fox Run Management L.L.C. purchased a new position in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 7,702 shares of the financial services provider's stock, valued at approximately $371,000.

Several other institutional investors and hedge funds have also modified their holdings of the business. Victory Capital Management Inc. bought a new position in shares of Trupanion in the third quarter worth about $261,000. Mutual of America Capital Management LLC acquired a new position in Trupanion during the 3rd quarter worth approximately $210,000. Quest Partners LLC bought a new position in Trupanion in the 3rd quarter valued at approximately $37,000. Intech Investment Management LLC lifted its stake in Trupanion by 73.6% in the 3rd quarter. Intech Investment Management LLC now owns 17,208 shares of the financial services provider's stock valued at $722,000 after purchasing an additional 7,298 shares during the last quarter. Finally, FMR LLC boosted its position in Trupanion by 55,963.7% in the third quarter. FMR LLC now owns 1,172,293 shares of the financial services provider's stock valued at $49,213,000 after buying an additional 1,170,202 shares in the last quarter.

Trupanion Trading Down 5.2 %

NASDAQ TRUP traded down $1.98 on Friday, reaching $36.25. The company had a trading volume of 443,337 shares, compared to its average volume of 646,663. The firm has a market cap of $1.54 billion, a price-to-earnings ratio of -157.61, a P/E/G ratio of 6.02 and a beta of 1.70. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.71 and a quick ratio of 1.66. Trupanion, Inc. has a fifty-two week low of $19.69 and a fifty-two week high of $57.90. The business has a 50 day moving average of $40.80 and a two-hundred day moving average of $46.52.

Remove Ads

Trupanion (NASDAQ:TRUP - Get Free Report) last issued its quarterly earnings results on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.06 by ($0.02). The company had revenue of $337.31 million during the quarter, compared to analyst estimates of $335.41 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. Analysts forecast that Trupanion, Inc. will post 0.13 EPS for the current year.

Insiders Place Their Bets

In related news, CFO Fawwad Qureshi sold 1,373 shares of the firm's stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $34.22, for a total transaction of $46,984.06. Following the completion of the sale, the chief financial officer now owns 2,416 shares of the company's stock, valued at $82,675.52. This trade represents a 36.24 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Margaret Tooth sold 4,000 shares of the business's stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $37.17, for a total value of $148,680.00. Following the completion of the transaction, the chief executive officer now directly owns 118,784 shares in the company, valued at approximately $4,415,201.28. This trade represents a 3.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 29,984 shares of company stock worth $999,042. 5.50% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on TRUP. Stifel Nicolaus dropped their price target on Trupanion from $44.00 to $41.00 and set a "hold" rating for the company in a research note on Thursday, February 20th. Piper Sandler dropped their target price on Trupanion from $57.00 to $52.00 and set an "overweight" rating for the company in a research report on Thursday, February 20th. Two investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $46.60.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.